OptimizeRx Corporation (OPRX)
NASDAQ: OPRX · Real-Time Price · USD
6.84
+0.10 (1.48%)
At close: Mar 9, 2026, 4:00 PM EDT
6.84
0.00 (0.00%)
After-hours: Mar 9, 2026, 4:00 PM EDT
OptimizeRx Revenue
In the year 2025, OptimizeRx had annual revenue of $109.43M with 18.78% growth. OptimizeRx had revenue of $32.24M in the quarter ending December 31, 2025, a decrease of -0.24%.
Revenue (ttm)
$109.43M
Revenue Growth
+18.78%
P/S Ratio
1.14
Revenue / Employee
$848,287
Employees
129
Market Cap
128.32M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 109.43M | 17.30M | 18.78% |
| Dec 31, 2024 | 92.13M | 20.61M | 28.81% |
| Dec 31, 2023 | 71.52M | 9.07M | 14.53% |
| Dec 31, 2022 | 62.45M | 1.16M | 1.89% |
| Dec 31, 2021 | 61.29M | 17.98M | 41.51% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| TruBridge | 347.27M |
| Health Catalyst | 316.06M |
| LifeMD | 250.09M |
| American Well | 249.33M |
| Definitive Healthcare | 241.52M |
| Spok Holdings | 139.71M |
| CareCloud | 114.32M |
| Simulations Plus | 78.68M |
OPRX News
- 3 days ago - OptimizeRx Warns Of Volatility From 'Most Favored Nation' Pricing Uncertainty - Benzinga
- 3 days ago - OptimizeRx Corporation (OPRX) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 3 days ago - UPDATE – OptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 3 days ago - OptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 4 weeks ago - OptimizeRx Sets Fourth Quarter and Full Year 2025 Financial Results Conference Call for March 5, 2026, at 4:30 p.m. ET - GlobeNewsWire
- 2 months ago - OptimizeRx and Experian Collaborate to Improve Privacy-Safe Identity Resolution in Healthcare Marketing - GlobeNewsWire
- 2 months ago - OptimizeRx Stock: A Buy-The-Dip Opportunity For This Above-Average Growth Story - Seeking Alpha
- 2 months ago - OptimizeRx Continues Expansion of the Company's Point-Of-Care Network - GlobeNewsWire